TRILAC CAPSULES

Indications

• Bladder cancer
• Tuberculosis vaccination

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on indication.

Adults: Refer to specific guidelines based on indication. For bladder cancer, a common regimen is instillation once a week for six weeks.

Mechanism of action

BCG works by stimulating the immune system, particularly through the activation of T-cells and macrophages. It enhances the immune response against tumor cells and Mycobacterium tuberculosis, promoting the release of cytokines and other immune mediators that contribute to the destruction of cancerous cells and pathogens.

Pharmacodynamics

The pharmacodynamics of BCG involve the induction of a robust immune response characterized by the activation of both innate and adaptive immunity. This includes the proliferation of T-lymphocytes and the production of cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukins, leading to increased immune surveillance and anti-tumor activity. The effectiveness of BCG is influenced by factors such as the host's immune status and the presence of any concurrent infections.

Pharmacokinetics

BCG is administered locally, and its pharmacokinetics are determined by the route of administration. After intravesical administration, BCG remains in the bladder and exerts its effects locally, with minimal systemic absorption. The half-life and clearance of BCG can vary based on the patient's immune response and presence of any concurrent conditions.

Interactions

• normal immunoglobulin + bacillus calmette-gurin vaccine: Unknown (decreases efficacy)

Pregnancy

Bacillus Calmette-Guérin (BCG) vaccine can be administered during pregnancy if the potential benefit outweighs the potential risk.

Breast-feeding

BCG vaccine may be administered during breastfeeding; however, caution is advised.

Storage

Store at 2-8 degrees Celsius. Do not freeze.

Formulations

• Bacillus Calmette-Guérin vaccine

Indications

• Inflammatory bowel disease
• Ulcerative colitis
• Crohn's disease
• Colorectal cancer prevention
• Gut health improvement

Dosage

Children: Refer to professional guidelines for specific dosing recommendations as it may vary based on the condition being treated and formulation used.

Adults: Refer to professional guidelines for specific dosing recommendations as it may vary based on the condition being treated and formulation used.

Mechanism of action

Butyricum exerts its effects primarily through the activation of G-protein coupled receptors (GPCRs), particularly the free fatty acid receptors (FFAR) such as FFAR2 and FFAR3. It also influences histone deacetylase (HDAC) activity, leading to altered gene expression. These mechanisms contribute to its anti-inflammatory properties and its role in regulating gut barrier function.

Pharmacodynamics

Butyricum is known to enhance colonic mucosal integrity and reduce inflammation by influencing immune cell activity. It promotes the production of mucus and the proliferation of colonic epithelial cells, contributing to the maintenance of a healthy gut environment. Furthermore, it has been shown to modulate metabolic processes, influencing insulin sensitivity and lipid metabolism.

Pharmacokinetics

Butyric acid is rapidly absorbed and metabolized in the intestines, with a short half-life. It is primarily distributed in the gut, where it acts locally, but it can also enter systemic circulation in small amounts. Its effects are predominantly localized to the gastrointestinal tract, where it contributes to the health of the intestinal lining and modulates gut microbiota composition.

Pregnancy

Safety during pregnancy has not been established. Consult healthcare providers before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult healthcare providers before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Botulism
• Tetanus
• Clostridium difficile infection
• Pseudomembranous colitis

Dosage

Adults: Refer to specific clinical guidelines for dosage based on the condition being treated, as Clostridium infections require targeted therapies and may involve antitoxins, antibiotics, or supportive

Mechanism of action

Clostridium species produce potent exotoxins that interfere with normal cellular functions. For instance, Clostridium botulinum produces botulinum toxin, which inhibits acetylcholine release at the neuromuscular junction, leading to paralysis. Clostridium tetani produces tetanospasmin, which blocks inhibitory neurotransmitter release in the central nervous system, resulting in muscle spasms. Clostridium difficile releases toxins A and B, which disrupt the intestinal epithelium and cause inflammation, leading to diarrhea.

Pharmacodynamics

The pharmacodynamic effects of Clostridium toxins are primarily driven by their enzymatic activities. Botulinum toxin is the most potent toxin known and acts at neuromuscular junctions, causing flaccid paralysis. Tetanospasmin affects central nervous system neurotransmission, leading to spastic paralysis. Toxins produced by Clostridium difficile lead to cell death and inflammatory responses in the colon, contributing to pseudomembranous colitis.

Pharmacokinetics

The pharmacokinetics of Clostridium infections vary by species and toxin type. Generally, the toxins are absorbed into circulation following local release at infection sites. For example, botulinum toxin is absorbed through the gastrointestinal tract when ingested and distributed throughout the body, while tetanospasmin acts locally and is transported retrograde along motor neurons to the central nervous system. The duration of action is influenced by the toxin's ability to bind to receptors and enter cells, as well as the body's capacity for toxin clearance.

Pregnancy

The safety of clostridium species during pregnancy has not been established. Caution is advised when administering to pregnant individuals.

Breast-feeding

The effects of clostridium species during breastfeeding are not well studied. Caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Specific storage conditions may vary based on formulation.

Indications

• Urinary tract infections
• Endocarditis
• Bacteremia
• Wound infections
• Intra-abdominal infections

Dosage

Children: Refer to BNF for Children for appropriate dosages tailored to the specific pediatric condition and the antibiotic prescribed.

Adults: Refer to established clinical guidelines and local protocols for dosing based on the specific antibiotic used and the infection being treated.

Mechanism of action

Enterococcus faecalis adheres to host tissues and can form biofilms, contributing to its pathogenicity. It possesses various virulence factors, including surface proteins that facilitate adherence and evasion of host immune responses. The bacterium's resistance mechanisms include the production of enzymes that degrade antibiotics and alterations in target sites that reduce the effectiveness of antimicrobial agents.

Pharmacodynamics

The pharmacodynamics of treatments targeting Enterococcus faecalis involve understanding the minimum inhibitory concentrations (MICs) of antibiotics against the organism. Antibiotics like ampicillin and vancomycin are commonly used, and their effectiveness is influenced by the organism's susceptibility profile. Resistance mechanisms, such as the production of enterococcal beta-lactamases and changes in penicillin-binding proteins, can affect treatment outcomes.

Pharmacokinetics

The pharmacokinetics of antibiotics used against Enterococcus faecalis vary. For example, the absorption, distribution, metabolism, and excretion of beta-lactam antibiotics like ampicillin can be influenced by renal function. These antibiotics are often administered intravenously in severe infections, with dosing adjustments necessary for patients with impaired renal clearance. The pharmacokinetic profile of vancomycin also necessitates monitoring of serum levels to avoid toxicity while ensuring therapeutic efficacy.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding has not been established.

Storage

Store at room temperature, away from direct light and moisture. Keep out of reach of children.

Indications

• Metabolic acidosis
• Lactic acidosis
• Support in shock or severe dehydration
• Exercise physiology research

Dosage

Children: Refer to clinical guidelines for specific dosing recommendations based on the clinical condition being treated.

Adults: Refer to clinical guidelines for specific dosing recommendations based on the clinical condition being treated.

Mechanism of action

Lactic acid primarily functions by contributing to the acid-base balance in the body. It can serve as a substrate for gluconeogenesis in the liver and is utilized in the Cori cycle, where it is converted back to glucose. Furthermore, lactic acid can act as a signaling molecule in various physiological processes, influencing metabolism and cellular responses during hypoxic conditions.

Pharmacodynamics

Lactic acid dissociates into lactate and hydrogen ions in solution, which can lead to a decrease in pH (acidosis) when produced in excess. Its accumulation in the body is indicative of anaerobic metabolism, often observed during intense exercise or in conditions of oxygen deprivation. The body can buffer the effects of lactic acid through bicarbonate and other mechanisms, maintaining homeostasis.

Pharmacokinetics

Lactic acid is rapidly absorbed and distributed throughout the body. It is metabolized primarily in the liver, where it can be converted to glucose or further metabolized to carbon dioxide and water. The elimination half-life of lactate varies depending on the metabolic state of the individual and the presence of underlying conditions. Renal function also plays a role in the clearance of lactate from the body.

Adverse effects

• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Hypersensitivity reactions

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of metabolic acidosis
• Caution in patients with liver disease

Pregnancy

Lactic acid is generally regarded as safe, but clinical use should be evaluated on a case-by-case basis during pregnancy.

Breast-feeding

Considered safe for use during breastfeeding, but consult healthcare provider for individual cases.

Storage

Store at room temperature, away from direct sunlight and moisture.

Formulations

• Lactic acid injection
• Lactic acid oral solution

Indications

• Mesenteric ischemia
• Chronic mesenteric ischemia
• Acute mesenteric ischemia
• Ischemic bowel disease

Dosage

Children: Refer to BNF for Children for appropriate dosing based on the condition being treated.

Adults: Refer to specific guidelines or BNF for appropriate dosing based on the condition being treated.

Mechanism of action

In diseases affecting the mesenteric circulation, therapeutic agents may work by improving blood flow, reducing clot formation, or addressing the underlying causes of ischemia. Agents like vasodilators act by relaxing blood vessels, thereby increasing blood flow to the mesenteric area. Antiplatelet or anticoagulant medications may be used to prevent thrombosis in mesenteric arteries.

Pharmacodynamics

The pharmacodynamics of drugs targeting mesenteric ischemia may involve the modulation of vascular tone and platelet aggregation. For example, vasodilators increase the diameter of blood vessels, which can enhance perfusion in areas affected by ischemia. Antiplatelet agents work by inhibiting the aggregation of platelets, thereby reducing the risk of clot formation in the mesenteric arteries.

Pharmacokinetics

The pharmacokinetics of drugs used in the management of mesenteric ischemia vary widely depending on the specific medication. Generally, absorption, distribution, metabolism, and excretion are key considerations. For instance, vasodilators may have a rapid onset of action and a short half-life, requiring careful dosing and monitoring. In contrast, antiplatelet agents may have longer half-lives, necessitating different dosing regimens.

Pregnancy

Use only if the benefits outweigh the risks, consult healthcare provider.

Breast-feeding

Use with caution, consult healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Streptococcal pharyngitis (strep throat)
• Scarlet fever
• Rheumatic fever
• Streptococcal skin infections (impetigo, cellulitis)
• Pneumonia caused by Streptococcus pneumoniae
• Meningitis caused by Streptococcus pneumoniae

Mechanism of action

Streptococcus bacteria adhere to host cells and evade the immune system through various mechanisms, including the production of virulence factors such as M protein and hyaluronic acid capsule, which inhibit phagocytosis. They can also release enzymes, such as streptolysins, that damage host tissues and facilitate the spread of infection. Antibiotics target the cell wall synthesis of these bacteria, ultimately leading to their lysis.

Pharmacodynamics

Streptococcus species exhibit varying susceptibility to antibiotics, with penicillin being highly effective against most strains, particularly Streptococcus pyogenes. Other antibiotics, such as macrolides and cephalosporins, may be used depending on the specific strain and patient allergies. The pharmacodynamics of antibiotics involve the inhibition of bacterial cell wall synthesis or protein synthesis, leading to bactericidal or bacteriostatic effects.

Pharmacokinetics

The pharmacokinetics of antibiotics used to treat streptococcal infections vary by agent. For example, penicillin is rapidly absorbed from the gastrointestinal tract and reaches peak plasma concentrations within 1 hour. It is widely distributed in body tissues and fluids, including the lungs and middle ear, and is primarily eliminated through renal excretion. The half-life of penicillin is approximately 30 minutes to 1 hour, necessitating multiple doses for effective treatment.

Pregnancy

Streptococcus species are generally not directly indicated as drugs but are associated with various infections. The use of antibiotics to treat infections caused by Streptococcus during pregnancy should be approached with caution and under medical supervision.

Breast-feeding

Antibiotics used to treat Streptococcus infections can be prescribed during breastfeeding, but the specific choice of antibiotic should be considered based on safety and efficacy.

Storage

Streptococcus as a bacterial genus does not have a storage guideline; however, antibiotics used to treat infections should be stored according to manufacturer instructions, typically in a cool, dry place away from light.